SCHEMBL7988129

SCHEMBL7988129

CCc1nc(O)c2c(ncn2Cc2ccc(O)cc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 3/20 0.44
HPGD P15428 2/20 0.35
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
TLR7 Q9NYK1 3/20 0.33
GAA P10253 1/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33
DBH P09172 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
BLM P54132 1/20 0.33
KMT2A Q03164 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNA4 P43681 1/20 0.32
ABCC8 Q09428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987434 0.91 CYP11B1 (0.42) METHPGDALDH1A1SMN1; SMN2TLR7
SCHEMBL7984526 0.90 MET (0.46) METHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL7975252 0.89 HPGD (0.45) HPGDALDH1A1SMN1; SMN2GAAPOLB
SCHEMBL7984468 0.87 ABCC8 (0.46) METHPGDALDH1A1SMN1; SMN2LMNA
SCHEMBL7973934 0.87 CYP11B1 (0.45) METHPGDALDH1A1SMN1; SMN2GAA
SCHEMBL8059823 0.87 MEN1 (0.45) HPGDALDH1A1SMN1; SMN2GAAPOLB
SCHEMBL7987782 0.85 NPC1 (0.44) HPGDALDH1A1SMN1; SMN2GAALMNA
SCHEMBL7984378 0.84 CYP11B1 (0.42) METHPGDALDH1A1SMN1; SMN2TLR7
SCHEMBL7985651 0.84 CYP1A2 (0.41) METHPGDALDH1A1SMN1; SMN2GAA
SCHEMBL7984754 0.83 SMN1; SMN2 (0.47) SMN1; SMN2GAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed